Article Information
History
- June 21, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Kareem A. Wahida,
- Jiaofeng Xub,
- Dina El-Habashya,c,
- Yomna Khamisa,d,
- Moamen Abobakra,
- Brigid McDonalda,
- Nicolette O’Connellb,
- Daniel Thillb,
- Sara Ahmeda,
- Christina Setareh Sharafia,
- Kathryn Prestona,
- Travis C Salzilloa,
- Abdallah Mohameda,
- Renjie Hea,
- Nathan Chob,
- John Christodouleasb,
- Clifton D. Fullera,* and
- Mohamed A. Nasera,*
- aDepartment of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
- bElekta AB, Stockholm, Sweden
- cDepartment of Clinical Oncology and Nuclear Medicine, Menoufia University, Shebin Elkom, Egypt
- dDepartment of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, Alexandria University, Alexandria, Egypt
- ↵*co-corresponding authors Corresponding author’s contact information: Clifton D. Fuller. Email: cdfuller{at}mdanderson.org. Mohamed A. Naser. Email: manaser{at}mdanderson.org. Postal Address: The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA.